Nurix Therapeutics, Inc. ($NRIX)
van Houte Hans โ Chief Financial Officer
Shares
93,750
Price
$0.00
Total Value
$0.00
Nearby Earnings
Jan 27, 2026
EPS:Est: -0.84
Revenue:Est: $13.41M
Jan 28, 2026
EPS:-0.82 (est: -0.84)-2.4%
Revenue:$13.58M (est: $15.60M)-13.0%
Transaction Details
| Insider | van Houte Hans |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Feb 10, 2026 |
| Expiration Date | Feb 9, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Employee Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 10, 2026 |
| Shares Purchased | 93,750 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 93,750 |
| Derivative | Derivative |
| Accession Number | 0001817217-26-000004 |
| Document | View SEC Filing |